Bristol Myers Squibb (BMY) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $0.53.
- Bristol Myers Squibb's EPS (Weighted Average and Diluted) rose 122500.0% to $0.53 in Q4 2025 from the same period last year, while for Dec 2025 it was $3.45, marking a year-over-year increase of 17805.43%. This contributed to the annual value of $3.46 for FY2025, which is 17845.8% up from last year.
- According to the latest figures from Q4 2025, Bristol Myers Squibb's EPS (Weighted Average and Diluted) is $0.53, which was up 122500.0% from $1.08 recorded in Q3 2025.
- In the past 5 years, Bristol Myers Squibb's EPS (Weighted Average and Diluted) registered a high of $1.2 during Q1 2025, and its lowest value of -$5.89 during Q1 2024.
- In the last 5 years, Bristol Myers Squibb's EPS (Weighted Average and Diluted) had a median value of $0.79 in 2024 and averaged $0.45.
- Per our database at Business Quant, Bristol Myers Squibb's EPS (Weighted Average and Diluted) skyrocketed by 127500.0% in 2021 and then crashed by 65046.73% in 2024.
- Quarter analysis of 5 years shows Bristol Myers Squibb's EPS (Weighted Average and Diluted) stood at $1.07 in 2021, then decreased by 11.21% to $0.95 in 2022, then decreased by 8.42% to $0.87 in 2023, then plummeted by 95.4% to $0.04 in 2024, then surged by 1225.0% to $0.53 in 2025.
- Its EPS (Weighted Average and Diluted) was $0.53 in Q4 2025, compared to $1.08 in Q3 2025 and $0.64 in Q2 2025.